Tim Betts, HRC 2019 – CABANA and CASTLE-AF in Practice
We spoke to Dr Tim Betts (Oxford University Hospitals NHS Trust, Oxford, UK) at the 2019 Heart Rhythm Congress (HRC) in Birmingham, UK, where he told us how the results from the CABANA and CASTLE-AF trials have changed his practice.
Speaker’s Disclosures: Tim Betts has received honoraria for consultancy and speaker fees from Abbott Medical, Boston Scientific and Acutus Medical.
1. How have CABANA and CASTLE-AF changed my practice? (0:09)
touchCARDIO.com is an independent information resource supporting physicians, clinicians and leading industry professionals in continuously developing their knowledge, effectiveness and productivity, via free-to-access content in multimedia formats.
Filmed at the Heart Rhythm Congress (HRC) 2019 in Birmingham, UK, October 2019 in partnership with Arrhythmia Alliance.
Share this Video
Related Videos In Atrial Fibrillation
Bruce Wilkoff, EHRA 2023: The AdaptResponse trial, synchronized left ventricular pacing for heart failure with left bundle branch block
The AdaptResponse trial was designed to assess two methods of restoring resynchronization to the heart in patients with heart failure with left bundle branch block. In this touchCARDIO interview, we speak with Dr Bruce Wilkoff (Cleveland Clinic, Cleveland, OH, USA) to discuss the design of the AdaptResponse trial, the outcomes as well as the clinical […]
Bruce Wilkoff, EHRA 2023: An overview of cardiac resynchronization therapy for patients with heart failure
Cardiac resynchronization therapy is designed to restore the electrical activation in a more natural way in patients with heart failure. In this touchCARDIO interview, we speak with Dr Bruce Wilkoff (Cleveland Clinic, Cleveland, OH, USA) to discuss the treatment paradigm with focus on cardiac resynchronization therapy for patients with heart failure. Bruce Wilkoff presented an […]
Søren Zöga Diederichsen, EHRA 2023: NT-proBNP as a tool for atrial fibrillation screening, post hoc analysis of the LOOP study
Recently it has been shown that NT-proBNP may be a useful tool for finding people with an increased risk of atrial fibrillation and stroke. In this touchCARDIO interview, we speak with Dr Søren Zöga Diederichsen (Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark) to discuss the post hoc analysis of the LOOP study. The abstract entitled ‘Atrial […]
Journal articles and more to your inbox
Get the latest clinical insights from touchCARDIOSign me up!